Medical Marijuana, Inc. (OTCBB: MJNA) Gets Clearance for Mexican Shipments and Reduces Debt

 

About Broad street alerts

Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.

Big opportunity in Small Cap’s during an overall market decline.

December 29^th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.

December 15^th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.

December 2^nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Street” to the phone number 25827 from your cell phone.

 

Brief Report for Medical Marijuana, Inc. (OTCBB: MJNA)

About Medical Marijuana Inc.

The mission of Medical Marijuana, Inc. (OTC Pink: MJNA) HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

According to a recent Reuters report, imports to Mexico are “restricted to products free of tetrahydrocannabinol (THC), the ingredient in marijuana that gets you ‘high’.” RSHO-X contains cannabidiol, the non-psychoactive component of the hemp plant. The report estimates the market in Mexico for cannabidiol (CBD) hemp oil to be $1-2 billion over ten years.

 

HempMeds® Mexico is offering three products:

Real Scientific Hemp Oil-X™ Gold Label CBD Hemp Oil in the 10 gram oral applicator contains 2,500mg cannabidiol

Real Scientific Hemp Oil-X™ Liquid Gold Label CBD Hemp Oil in 4 fl. oz. bottle contains 1,000mg cannabidiol

Real Scientific Hemp Oil-X™ Liquid Gold Label CBD Hemp Oil in 8 fl. oz. bottle contains 5,000mg cannabidiol

 

MJNA has significantly reduced its debt obligation from $24 million at the close of the third quarter (ending 9/30/2015) to approximately $10 million at the close of the fourth quarter (ending 12/31/2015), a reduction of approximately $14 million. The Company also acquired and consolidated several of its partnerships including 93.4% of HempMeds® Brasil™, LLC and the remaining 20% of HempMeds® PX that Medical Marijuana, Inc. did not already own from affiliated parties that comprise the largest shareholder of the Company.

Prior to the acquisitions, the Company sold its RSHO™ products to HempMeds Brasil™ and the other consolidated companies at wholesale, which then in turn sold those products retail to consumers in their respective markets. As a result of the acquisitions, the Company will now realize the full margin between the cost of manufacturing the product and retail pricing on the sales of the product.

The combined purchase price for the acquisition of 93.4% of HempMeds® Brasil™ and 20% of HempMeds® PX was $13,875,000. Under the terms of the acquisitions, the purchase price is subject to downward adjustment if the aggregate post-acquisition valuation of both entities (as of the transaction date of December 31, 2015) by a recognized independent valuation firm is less than the purchase price and is not subject to upward adjustment unless the aggregate valuation is greater than $100 million (as of December 31, 2015) and such upward valuation is nonetheless subject to a cap of $20 million.

 

Broad street alerts has compensated the author of this report (LIX Research) up to two hundred fifty dollars for the redistribution rights for a period of 30 days. Broad street alerts and parent company Small cap specialists LLC have not been compensated in any way for this post.

About Broad street alerts

Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.

Big opportunity in Small Cap’s during an overall market decline.

December 29^th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.

December 15^th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.

December 2^nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Street” to the phone number 25827 from your cell phone.

 

Hemp, Inc. (OTCBB: HEMP)

About Hemp, Inc.

Hemp, Inc.’s mission is to provide green solutions that help make the world a better place to live. We support products that are ecofriendly, organic, healthy, and solutions that replace many petroleum-based products.

 

Hemp, Inc.’s wholly owned subsidiary Industrial Hemp Manufacturing, LLC purchased the largest decortication plant in North America, which is located in Spring Hope, North Carolina. The plant is housed in a 70,000 square foot warehouse on 9 acres. The company will start producing fiber, loss circulation materials (LCM) and absorbents from kenaf and later from hemp.

 

Initially, Hemp, Inc. will produce a product for drilling rigs called “lost circulation material” (LCM), which is used for maintaining the seals when drilling for water, oil, gas, and any other liquid or gas. This product alone is capable of producing millions of dollars in revenue, since some of the largest oil companies in the world will be our primary customers.

Eventually, the company will produce fiber materials for the paper and fabric industries, and other industries that utilize materials from hemp to make products such as plastics, building materials, health and beauty related products and more.

Due to the current exemption to growing hemp that was established under the 2014 Federal Farm Bill several states, are looking at bills regarding the cultivation of hemp. http://www.otcmarkets.com/stock/HEMP/news/More-States-Legalize-Hemp—Update-by-Hemp–Inc-?id=124219&b=y

Last month the company posted a review of its 2015 achievements and its outlook for 2016. The full article can be reviewed at http://www.otcmarkets.com/stock/HEMP/news/Hemp–Inc–s-2015-Year-in-Review–amp–What-s-Next-for-2016?id=123210&b=y

 

 

Broad street alerts has compensated the author of this report (LIX Research) up to two hundred fifty dollars for the redistribution rights for a period of 30 days. Broad street alerts and parent company Small cap specialists LLC have not been compensated in any way for this post.

 

About Broad street alerts

Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.

Big opportunity in Small Cap’s during an overall market decline.

December 29^th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.

December 15^th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.

December 2^nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long term potential for our members.

***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “alerts” to the phone number 25827 from your cell phone.

 

Report- GeoVax Labs, Inc. (OTCQB: GOVX)

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases using its Modified Vaccinia Virus Ankara – Virus-Like Particle (MVA-VLP) vaccine platform. The Company also recently began a program to evaluate the use of its MVA-VLP platform in cancer immunotherapy. GeoVax’s most advanced development programs are focused on vaccines against HIV and hemorrhagic fever viruses (Ebola, Marburg, and Lassa).

 

On February 1, 2016, the World Health Organization (WHO) designated the Zika virus and its suspected complications in newborns an international public health emergency. The Zika epidemic, currently in 24 countries in the Americas, is transmitted by the Aedes mosquito and is expected by the WHO to reach most of the Western Hemisphere, infecting up to 4 million people by year’s end. The Centers for Disease Control and Prevention (CDC) has issued a travel advisory for people traveling to regions within the Zika virus outbreak, which include popular vacation destinations. Brazil, the site of the 2016 Summer Olympic Games, is included in the advisory. More than 30 cases have been reported in the United States, imported by travelers visiting affected regions.

 

Zika virus is a member of the Flaviviridae family, which includes dengue fever, yellow fever, Japanese encephalitis, tick-borne encephalitis, and West Nile viruses. There is an alarming association between Zika infections and severe birth defects, including over 4000 cases of microcephaly in Brazil since fall 2015, 270 of which show confirmed evidence of infection. Microcephaly is a congenital condition marked by an abnormally small head and incomplete brain development. A potential link to Zika infection is also suspected in adults diagnosed with Guillain-Barré syndrome, a rare autoimmune disorder that can cause paralysis.

 

Other than mosquito control, no approved preventive or therapeutic products are currently available to fight Zika infections. Public health officials recommend avoiding exposure to Zika, delaying pregnancy, and following basic supportive care after infection. A vaccine is urgently needed to prevent a Zika pandemic.

 

GOVX has begun a program to develop a vaccine for the prevention of Zika virus infections using its novel MVA-VLP vaccine platform. The company believes that it can rapidly advance a vaccine candidate to human clinical testing. GeoVax’s Senior Vice President of Research and Development, Farshad Guirakhoo, PhD, will lead the company’s effort in developing a Zika virus vaccine. Dr. Guirakhoo played pivotal roles in the development and licensure of human vaccines against Flaviviruses including dengue and Japanese encephalitis. His extensive experience and expertise with Flavivirus vaccine development gives the company an advantage over competitors and will shorten the time until a Zika vaccine can be brought to market by GeoVax and its partners. GeoVax has also entered into a Collaborative Research Agreement with the University of Georgia to speed development of the vaccine.

 

 

Broad street alerts has compensated the author of this report (LIX Research) up to two hundred fifty dollars for the redistribution rights for a period of 30 days. Broad street alerts and parent company Small cap specialists LLC have not been compensated in any way for this post.

Analyst Report: Aluf Holdings, Inc. (OTCBB: AHIX)

 

Aluf Holdings Inc           

A Company of Champions Navigating the 21st Century

 

Aluf Holdings, Inc. (AHIX) is a holding company headquartered in Hollywood, FL, engaged in acquiring, operating and managing subsidiary companies in the development and sale of proprietary software. The goal of AHIX is to strategically acquire profitable businesses with strong growth potential and a solid business plan in the software and technology industries.

 

 

 

 

KEY STATISTICS:

Market Value: $215,521 a/o Jan 29, 2016

Authorized Shares 946,821,999 a/o Jan 18, 2016

Outstanding Shares 269,401,339 a/o Jan 18, 2016

Float 167,828,512 a/o Jan 18, 2016

 

 

RECENT NEWS:

HOLLYWOOD, FL / ACCESSWIRE / December 30, 2015 / Aluf Holdings, Inc. (PINKSHEETS: AHIX) today announced that it has entered into a definitive agreement with Triad Biometrics, LLC, a biometric software innovator formed in 2004, to acquire its assets consisting of intellectual property and software products including “undefeatable” FIPS 140-2 Suite B military grade encryption, among other ground breaking features. This announcement stems from the previously reported LOI that Aluf Holdings, Inc. signed with Triad Biometrics on August 20th.

Pursuant to the terms of the Purchase Agreement, the Company will pay Triad US$3,750,000 for the Assets. Closing of the Acquisition is subject to, amongst other things, the completion of satisfactory due diligence by the Company, and the Company securing satisfactory financing.

Aluf Holdings, Inc. is the creator of proprietary software with installations worldwide. The definitive agreement lays the foundation for the transferal of Triad’s assets to a newly formed subsidiary, Aluf Biometrics, Inc., that will develop and enhance a suite of next generation biometric identification and authentication products. Aluf Holdings’ business plan is focused on the profitable operation and management of subsidiary companies in the development of proprietary groundbreaking software that businesses and individuals will find unsurpassed in function and usefulness.

HOLLYWOOD, FL / ACCESSWIRE / November 12, 2015 / Aluf Holdings, Inc. (PINKSHEETS: AHIX) today announced that it has reached a Joint Venture Agreement with Vanderbilt Bonds. Vanderbilt Bonds will provide up to $5 million USD in financing to acquire the Biometric IP assets which will be transferred into its new operating entity, Aluf Biometrics, Inc.

 

About Triad Biometrics, LLC:

Triad Biometrics, LLC, developed TEAMS(R), a groundbreaking enterprise level fingerprint biometric identification and authentication product that is setting a new paradigm for security, interoperability, and accountability. TEAMS(R) represents the next-generation in securely accessing web based applications. By enabling the elimination of passwords and password fields, data security, end user experience, and productivity are significantly improved while authentication-related maintenance and operating costs are reduced. User frustration and risk associated with finding, remembering, and storing passwords is eliminated. Unlike other commercial biometric systems, TEAMS(R) is an autonomous authentication method with no reliance on directory or other password-based systems, and once implemented, cannot be hacked, cracked, or circumvented. TEAMS(R) utilizes military-grade FIPS-140 Suite B cryptography in concert with several unique patented and pending features which enable a never-before-obtained level of identity confidence, privacy protection, and data security over un-trusted networks, such as the public internet.

 

 

BIOMETRICS MARKET:

Biometrics Research Group Inc. projects that the global biometrics market will grow to US$35.5 billion by 2020 from its 2015 value of US$15 billion. The market for automated fingerprint identification systems and fingerprint biometric technologies account for the greatest share of the global biometrics market and is forecast to continue to be the main source of overall market revenues from 2015 to 2020.

Biometric authentication is a technology that automatically confirms a person’s identity by comparing patterns of physical or behavioral characteristics in real time against enrolled computer records of those patterns. Leading biometric technologies accomplish this task by scanning patterns of the face, fingerprint, hand, iris, palm, signature, skin, or voice and storing then electronically in a secure, encrypted format.

Importantly, biometric identification is far superior to other common means of confirming identity, such as tokens (something one possesses) or passwords (something one knows). Tokens (drivers’ licenses, for example) and passwords (Social Security numbers, for example) cannot assure positive identification of a person. Tokens are routinely counterfeited and stolen. Passwords are routinely forgotten, left in plain sight, and stolen. Unlike tokens or passwords, biometric identifiers are inextricably linked to individuals themselves and, therefore, cannot be forgotten or stolen.

Biometric authentication also helps protect privacy by erecting a barrier between personal data and unauthorized access. Technically, biometric capture devices create electronic digital reference templates that are encrypted and stored and then compared to encrypted templates derived from “live” images in order to confirm a the identity of a person. The templates are generated from complex and proprietary algorithms and are then encrypted using strong cryptographic techniques to secure and protect them from disclosure. Thus, standing alone, biometric templates cannot be reconstructed, decrypted, reverse-engineered, or otherwise manipulated to reveal a person’s identity. In short, biometrics can be thought of as a very secure key: unless a biometric gate is unlocked by using the right key, no one can gain access to a person’s identity. Source: IBIA.org

 

MANAGEMENT TEAM:

Teresa McWilliams currently serves as interim CEO of Aluf Holdings, Inc. She still retains her permanent title of Chief Financial Officer and senior manager where she has served since June 2011. Teresa began her professional career in finance with Merrill Lynch, later moving on to a regional CPA firm. Teresa branched out to work in securities as the Compliance Officer and Corporate Controller for a broker-dealer. In 1998 Teresa founded and operated a professional tax and business consulting firm specializing in compliance, accounting, business and personal tax issues, as well as C-level executive consulting services where she participated in a number of IPO’s and Mergers & Acquisitions.

Larry W Hawkes – Chief Operations and Technology Officer  is a 30 year veteran of the software industry. Larry has managed large (multi-million $) software integration projects. He has been a software retailer, a software application manager, a project manager, a database developer, a database administrator and a software developer all at a senior level.

Yonghun Kim – Director

Dale Churchill – Director

Jonathan Baker – Director

Michael Brauner – Director

Larry G. Striggles – Director

Donald Bennett – Board Advisor

 

CONCLUSION:

In the past 18 months the following have happened at AHIX:

Name change and ticker symbol change.

Elimination or settlement of several lawsuits the company was involved with.

Settlement or otherwise reorganized much of the corporate debt.

Released the former Interim CEO from a two year contract.

Cancelled an ineffectual consulting agreement.

Lined up a $5 million credit facility for acquisitions.

Purchased the assets of Triad Biometrics LLC.

Completed a 2500 for 1 reverse stock split to benefit shareholders.

You can read about these events in further detail in the AHIX Quarterly Report published November 11, 2015 for the period ended September 30, 2015 and found at this link http://www.otcmarkets.com/financialReportViewer?symbol=AHIX&id=146687

 

It should be first noted that the projected increase in the biometrics market mentioned above, represents a 133% increase over just 5 years. That is remarkable even in today’s plethora of high growth industries.

ALUF maintains a marginal revenue stream from the software assets of its COREwafer days. That revenue has been declining over several quarters and one may expect it to decline further. Since Triad was not a public company we don’t know what level of revenue, if any they have achieved to add to the ALUF top line.

The current price is $.0007 or 100,000 shares for $70 bucks. Savvy investors may realize these shares are vastly oversold and get in on this bargain.

 

 

 

 

DISCLAIMER

Broadstreetalerts.com has compensated the author of this report up to two hundred and fifty dollars for the redistribution rights for a period of up to 30 days.

Broadstreetalerts.com is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC. SCS LLC has been compensated Fifteen Hundred Dollars by Micro Cap Equities LLC to disseminate this report about Aluf Holdings (OTCBB: AHIX)

Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We have not been compensated in any form by any entity for this report. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

PLEASE NOTE WELL: SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold SCS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.

SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. SCS LLC is not a Broker/Dealer and does not engage in high frequency trading.

Please click the link below to view the CYDY analyst report

Report Link- CYDY Analyst Report